 DecisionBase PDFs --
2008
 In This Issue...
Empowering Decision Makers with Robust Interactive Data and Analysis...
Drug development
isn't what it used to be. Gone are the days of relying on blockbusters. Instead
the drug industry is faced with identifying incremental drug improvements that
will be commercially compelling.
In response to these
changing times, Decision Resources has completely revamped its data and
analysis tool, DecisionBase, to better address the needs of the industry.
DecisionBase 2008 combines market forecasts with clinical and commercial
endpoints to assess market share projections in 35 indications. These outputs
are driven by quantitative and qualitative primary research.
DecisionBase 2008 provides
detailed market share, patient share, and price-per-day projections for
emerging drugs in development. The market share projections are based on
prescriber surveys that compare physicians' expectations of a potential target
product profile with an emerging product profile of the leading drugs in
development. The forecast is built upon evaluation of commercial and clinical
drivers that impact the market. In the commercial environment, we examine
pricing, reimbursement, and regulatory issues. The clinical environment
includes assessment of current therapies, patient population, and quality of
life measures.
- Market forecast information including diagnosis rates, drug-treated, patient share, price-per-day, and compliance rates.
- Commercial information including pricing, reimbursement, labeling, and regulatory history.
- Clinical measurements including current therapies, patient population, and quality of life measures.
|
